Cardio-Oncology: State-of-the-Art Reviews

Dear Colleagues,

Mortality rates from cancer have declined over the past three decades largely due to early detection strategies and advances in cancer therapeutics. However, the improvement of cancer survivorship often comes with an increased risk of cardiovascular morbidity and mortality. Cardio-oncology, a new interdisciplinary discipline, ames to address the complexity of intersection and interplay of cardiovascular diseases and cancer. Several types of anti-cancer treatments have been associated with potential cardiovascular toxicity. An example is anthracycline exposure which may lead to potentially irreversible cardiac dysfunction. Myocarditis induced by immune checkpoint inhibitors has now emerged as a new challenge in clinical care. Proteasome inhibitors and a plethora of other targeted cancer therapies have been reported to potentially cause cardiovascular toxicity. It is of great importance to investigate the mechanisms of cancer treatment-related cardiovascular complications as well as their prevention and therapeutic strategies.

This special issue requests submissions about cardiovascular toxicity associated with anticancer treatment. We welcome original research and review articles from cardiologists, oncologists, pharmacists and other investigators.

Potential topics include but are not limited to the following:
• An overview of cardiovascular toxicity related to novel anticancer treatments.
• Determining the best method for cardiac monitoring such as electrocardiogram, echocardiogram and cardiac biomarkers.
• Assessing the potential mechanisms and pathophysiology of cardiovascular toxicity associated with cancer treatments.
• Prevention and treatment strategies for anticancer related cardiovascular toxicity.
• Identification of shared mechanisms along with common risk factors related to cancer and cardiovascular diseases.

Prof. Tong Liu, Ying Liu and Leilei Cheng
Guest Editors

Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2200 USD. Submitted manuscripts should be well formatted in good English.